| Xeno | |
|---|---|
&sq=Facebook&lang=en&file=File:Xenoblade_Chronicles_logo.png){kind=logo} The logo for the Xenoblade Chronicles franchise. Each Xeno franchise has a stylistically distinct logo. | |
| Genre(s) | Role-playing video game |
| Developer(s) | Square, Monolith Soft |
| Publisher(s) | Square, Bandai Namco, Nintendo |
| Creator(s) | Tetsuya Takahashi, Soraya Saga |
| Platform(s) | PlayStation, PlayStation 2, Mobile, Nintendo DS, New Nintendo 3DS, Wii, Wii U, Nintendo Switch |
| First release | Xenogears February 11, 1998 |
| Latest release | Xenoblade Chronicles 3: Future Redeemed April 25, 2023 |
| Spin-offs | Xenosaga Xenoblade Chronicles |
Xeno[a] is a Japanese science fantasy video game franchise created by Tetsuya Takahashi. The first entry was developed by SquareSoft, and subsequent entries have been developed by Monolith Soft, a company founded by Takahashi after he left Square in 1999. While the various games have no direct story connections, they have common thematic links and all sport the "Xeno" prefix, which Takahashi has variously described as a means of identifying his games and a symbolic representation of the series. All the games in the Xeno meta series take place within a science fiction setting with some fantasy elements, with its stories frequently featuring psychological, philosophical, and religious themes.
The first title, Xenogears, was originally proposed as a storyline for Final Fantasy VII, as well as a sequel to the 1995 RPG Chrono Trigger, but was allowed to be developed as its own project. After Square shifted its focus onto the Final Fantasy series, Takahashi and several other Xenogears staff founded Monolith Soft and began work on the Xenosaga games. Both Xenogears and Xenosaga were intended to be six-part series, but differing circumstances caused plans to be cut down. After the premature end of the Xenosaga series, Monolith Soft began developing Xenoblade Chronicles, initially intended to be an original title. The games of the Xeno franchise have generally sold well and received positive press worldwide.
Cite error: There are <ref group=lower-alpha> tags or {{efn}} templates on this page, but the references will not show without a {{reflist|group=lower-alpha}} template or {{notelist}} template (see the help page).